Barry Ticho, CHIEF MEDICAL OFFICER at Stoke Therapeutics, Inc. (STOK), sold 49,421 shares at $10.03 ($496K) on 2025-05-02, disclosed to the SEC on 2025-05-05.
Scheduled sale ($496k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 3,841 | $38K | 7.8% |
| 2 | $10.03 | 22,790 | $229K | 46.1% |
| 3 | $10.03 | 22,790 | $229K | 46.1% |
| Total | $10.03 avg | 49,421 | $496K | 100% |
| Filing → |
| STOK | SELL | 2026-08-18 | $153K | — | Filing → |
| STOK | SELL | 2026-08-05 | $208K | — | Filing → |
| STOK | SELL | 2026-07-06 | $236K | — | Filing → |